According to Figure 9, the group with high expression of S100A11, S100A13, S100A16, S100B, and S100PBP showed shorter OS relative to the group with low expression for all patients with glioma in the TCGA database (P < 0.001). The gene discussed is S100PBP; the disease is central nervous system cancer.